Intra-Cellular Therapies Inc. buy Needham & Company LLC
Start price
03.08.23
/
50%
€53.70
Target price
03.08.24
€66.63
Performance (%)
14.53%
Price
16.05.24
€61.50
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL currently has a performance of 14.53%. This prediction currently runs until 03.08.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -0.806% | -0.806% |
iShares Core DAX® | -0.051% | 4.829% |
iShares Nasdaq 100 | 1.659% | 2.417% |
iShares Nikkei 225® | 0.658% | -2.173% |
iShares S&P 500 | 0.964% | 2.547% |
Comments by Needham___Company_LL for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $73.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Needham___Company_LL for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
07.05.24
07.05.24
€83.49
07.05.25
07.05.25
-3.91%
16.05.24
16.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€70.50
22.04.24
22.04.24
€84.46
22.04.25
22.04.25
-12.77%
16.05.24
16.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
05.04.24
05.04.24
€75.83
05.04.25
05.04.25
-3.91%
16.05.24
16.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.50
23.02.24
23.02.24
€75.68
23.02.25
23.02.25
-3.15%
16.05.24
16.05.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€56.40
20.04.23
20.04.23
€60.11
20.04.24
20.04.24
22.34%
21.04.24
21.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€60.85
29.03.24
29.03.24
22.14%
30.03.24
30.03.24